Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

MTS expects to receive half of its revenue from non-telecommunications services

5/15/24 MTSS

Head of the Supervisory Board of the Moscow Exchange vustpil with an initiative to support minority shareholders

5/15/24 MOEX

M. Video-Eldorado reports sales growth in the first quarter

5/15/24 MVID

Shareholders of Novolipetsk Iron and Steel Works approved dividends for 2023

5/15/24 NLMK

"Euromedicenter" refused to pay dividends

5/14/24 GEMC

Shareholders of Acron approved dividends for 2023

5/14/24 AKRN

The Moscow Exchange announced the date of delisting of Yandex N. V. shares

5/14/24 YDEX

The Moscow Exchange announced the date of delisting of Yandex N. V. shares

5/14/24 YNDX

St. Petersburg Stock Exchange determined the main directions of development of the platform

5/14/24 SPBE

Aeroflot increases passenger traffic in April 2024

5/14/24 AFLT